TY - JOUR AU - Davies, H. AU - Bignell, G. R. AU - Cox, C. AU - Stephens, P. AU - Edkins, S. AU - Clegg, S. PY - 2002 DA - 2002// TI - Mutations of the BRAF gene in human cancer JO - Nature VL - 417 UR - https://doi.org/10.1038/nature00766 DO - 10.1038/nature00766 ID - Davies2002 ER - TY - JOUR AU - Holderfield, M. AU - Deuker, M. M. AU - McCormick, F. AU - McMahon, M. PY - 2014 DA - 2014// TI - Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3760 DO - 10.1038/nrc3760 ID - Holderfield2014 ER - TY - JOUR AU - Poulikakos, P. I. AU - Rosen, N. PY - 2011 DA - 2011// TI - Mutant BRAF melanomas--dependence and resistance JO - Cancer Cell VL - 19 UR - https://doi.org/10.1016/j.ccr.2011.01.008 DO - 10.1016/j.ccr.2011.01.008 ID - Poulikakos2011 ER - TY - STD TI - Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363(9):809–19. ID - ref4 ER - TY - JOUR AU - Chapman, P. B. AU - Hauschild, A. AU - Robert, C. AU - Haanen, J. B. AU - Ascierto, P. AU - Larkin, J. PY - 2011 DA - 2011// TI - Improved survival with vemurafenib in melanoma with BRAF V600E mutation JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1103782 DO - 10.1056/NEJMoa1103782 ID - Chapman2011 ER - TY - JOUR AU - Hartsough, E. AU - Shao, Y. AU - Aplin, A. E. PY - 2014 DA - 2014// TI - Resistance to RAF inhibitors revisited JO - J Invest Dermatol VL - 134 UR - https://doi.org/10.1038/jid.2013.358 DO - 10.1038/jid.2013.358 ID - Hartsough2014 ER - TY - STD TI - Trunzer K, Pavlick AC, Schuchter L, Gonzalez R, McArthur GA, Hutson TE, et al. Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31(14):1767–74. ID - ref7 ER - TY - JOUR AU - Spain, L. AU - Julve, M. AU - Larkin, J. PY - 2016 DA - 2016// TI - Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations JO - Expert Opin Pharmacother VL - 17 UR - https://doi.org/10.1517/14656566.2016.1168805 DO - 10.1517/14656566.2016.1168805 ID - Spain2016 ER - TY - STD TI - Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Bastholt L, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - update 2016. Eur J Cancer. 2016;63:201–17. ID - ref9 ER - TY - JOUR AU - Boroughs, L. K. AU - DeBerardinis, R. J. PY - 2015 DA - 2015// TI - Metabolic pathways promoting cancer cell survival and growth JO - Nat Cell Biol VL - 17 UR - https://doi.org/10.1038/ncb3124 DO - 10.1038/ncb3124 ID - Boroughs2015 ER - TY - JOUR AU - Hay, N. PY - 2016 DA - 2016// TI - Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.77 DO - 10.1038/nrc.2016.77 ID - Hay2016 ER - TY - JOUR AU - Yun, J. AU - Rago, C. AU - Cheong, I. AU - Pagliarini, R. AU - Angenendt, P. AU - Rajagopalan, H. PY - 2009 DA - 2009// TI - Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells JO - Science VL - 325 UR - https://doi.org/10.1126/science.1174229 DO - 10.1126/science.1174229 ID - Yun2009 ER - TY - STD TI - Parmenter TJ, Kleinschmidt M, Kinross KM, Bond ST, Li J, Kaadige MR, et al. Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discov. 2014;4(4):423–33. ID - ref13 ER - TY - JOUR AU - Patel, M. S. AU - Korotchkina, L. G. PY - 2001 DA - 2001// TI - Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases JO - Exp Mol Med VL - 33 UR - https://doi.org/10.1038/emm.2001.32 DO - 10.1038/emm.2001.32 ID - Patel2001 ER - TY - JOUR AU - Korotchkina, L. G. AU - Patel, M. S. PY - 1995 DA - 1995// TI - Mutagenesis studies of the phosphorylation sites of recombinant human pyruvate dehydrogenase. Site-specific regulation JO - J Biol Chem VL - 270 UR - https://doi.org/10.1074/jbc.270.24.14297 DO - 10.1074/jbc.270.24.14297 ID - Korotchkina1995 ER - TY - JOUR AU - Patel, M. S. AU - Korotchkina, L. G. PY - 2006 DA - 2006// TI - Regulation of the pyruvate dehydrogenase complex JO - Biochem Soc Trans VL - 34 UR - https://doi.org/10.1042/BST0340217 DO - 10.1042/BST0340217 ID - Patel2006 ER - TY - JOUR AU - Sugden, M. C. AU - Holness, M. J. PY - 2006 DA - 2006// TI - Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases JO - Arch Physiol Biochem VL - 112 UR - https://doi.org/10.1080/13813450600935263 DO - 10.1080/13813450600935263 ID - Sugden2006 ER - TY - JOUR AU - Huang, B. AU - Gudi, R. AU - Wu, P. AU - Harris, R. A. AU - Hamilton, J. AU - Popov, K. M. PY - 1998 DA - 1998// TI - Isoenzymes of pyruvate dehydrogenase phosphatase. DNA-derived amino acid sequences, expression, and regulation JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.28.17680 DO - 10.1074/jbc.273.28.17680 ID - Huang1998 ER - TY - JOUR AU - Walbrecq, G. AU - Wang, B. AU - Becker, S. AU - Hannotiau, A. AU - Fransen, M. AU - Knoops, B. PY - 2015 DA - 2015// TI - Antioxidant cytoprotection by peroxisomal peroxiredoxin-5 JO - Free Radic Biol Med VL - 84 UR - https://doi.org/10.1016/j.freeradbiomed.2015.02.032 DO - 10.1016/j.freeradbiomed.2015.02.032 ID - Walbrecq2015 ER - TY - JOUR AU - Haan, C. AU - Behrmann, I. PY - 2007 DA - 2007// TI - A cost effective non-commercial ECL-solution for western blot detections yielding strong signals and low background JO - J Immunol Methods VL - 318 UR - https://doi.org/10.1016/j.jim.2006.07.027 DO - 10.1016/j.jim.2006.07.027 ID - Haan2007 ER - TY - JOUR AU - Boing, I. AU - Stross, C. AU - Radtke, S. AU - Lippok, B. E. AU - Heinrich, P. C. AU - Hermanns, H. M. PY - 2006 DA - 2006// TI - Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases JO - Cell Signal VL - 18 UR - https://doi.org/10.1016/j.cellsig.2005.03.015 DO - 10.1016/j.cellsig.2005.03.015 ID - Boing2006 ER - TY - JOUR AU - Margue, C. AU - Philippidou, D. AU - Reinsbach, S. E. AU - Schmitt, M. AU - Behrmann, I. AU - Kreis, S. PY - 2013 DA - 2013// TI - New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0073473 DO - 10.1371/journal.pone.0073473 ID - Margue2013 ER - TY - JOUR AU - Ivashchenko, O. AU - Van Veldhoven, P. P. AU - Brees, C. AU - Ho, Y. S. AU - Terlecky, S. R. AU - Fransen, M. PY - 2011 DA - 2011// TI - Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk JO - Mol Biol Cell VL - 22 UR - https://doi.org/10.1091/mbc.E10-11-0919 DO - 10.1091/mbc.E10-11-0919 ID - Ivashchenko2011 ER - TY - JOUR AU - Dooley, C. T. AU - Dore, T. M. AU - Hanson, G. T. AU - Jackson, W. C. AU - Remington, S. J. AU - Tsien, R. Y. PY - 2004 DA - 2004// TI - Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M312847200 DO - 10.1074/jbc.M312847200 ID - Dooley2004 ER - TY - JOUR AU - Hanson, G. T. AU - Aggeler, R. AU - Oglesbee, D. AU - Cannon, M. AU - Capaldi, R. A. AU - Tsien, R. Y. PY - 2004 DA - 2004// TI - Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M312846200 DO - 10.1074/jbc.M312846200 ID - Hanson2004 ER - TY - JOUR AU - Hatzivassiliou, G. AU - Song, K. AU - Yen, I. AU - Brandhuber, B. J. AU - Anderson, D. J. AU - Alvarado, R. PY - 2010 DA - 2010// TI - RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth JO - Nature VL - 464 UR - https://doi.org/10.1038/nature08833 DO - 10.1038/nature08833 ID - Hatzivassiliou2010 ER - TY - JOUR AU - Poulikakos, P. I. AU - Zhang, C. AU - Bollag, G. AU - Shokat, K. M. AU - Rosen, N. PY - 2010 DA - 2010// TI - RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF JO - Nature VL - 464 UR - https://doi.org/10.1038/nature08902 DO - 10.1038/nature08902 ID - Poulikakos2010 ER - TY - JOUR AU - Kuschel, A. AU - Simon, P. AU - Tug, S. PY - 2012 DA - 2012// TI - Functional regulation of HIF-1alpha under normoxia--is there more than post-translational regulation? JO - J Cell Physiol VL - 227 UR - https://doi.org/10.1002/jcp.22798 DO - 10.1002/jcp.22798 ID - Kuschel2012 ER - TY - JOUR AU - Sheta, E. A. AU - Trout, H. AU - Gildea, J. J. AU - Harding, M. A. AU - Theodorescu, D. PY - 2001 DA - 2001// TI - Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204972 DO - 10.1038/sj.onc.1204972 ID - Sheta2001 ER - TY - JOUR AU - Kuphal, S. AU - Winklmeier, A. AU - Warnecke, C. AU - Bosserhoff, A. K. PY - 2010 DA - 2010// TI - Constitutive HIF-1 activity in malignant melanoma JO - Eur J Cancer VL - 46 UR - https://doi.org/10.1016/j.ejca.2010.01.031 DO - 10.1016/j.ejca.2010.01.031 ID - Kuphal2010 ER - TY - JOUR AU - Saunier, E. AU - Benelli, C. AU - Bortoli, S. PY - 2016 DA - 2016// TI - The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents JO - Int J Cancer VL - 138 UR - https://doi.org/10.1002/ijc.29564 DO - 10.1002/ijc.29564 ID - Saunier2016 ER - TY - JOUR AU - Zheng, B. AU - Jeong, J. H. AU - Asara, J. M. AU - Yuan, Y. Y. AU - Granter, S. R. AU - Chin, L. PY - 2009 DA - 2009// TI - Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation JO - Mol Cell VL - 33 UR - https://doi.org/10.1016/j.molcel.2008.12.026 DO - 10.1016/j.molcel.2008.12.026 ID - Zheng2009 ER - TY - JOUR AU - Sueda, T. AU - Sakai, D. AU - Kawamoto, K. AU - Konno, M. AU - Nishida, N. AU - Koseki, J. PY - 2016 DA - 2016// TI - BRAF V600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells JO - Sci Rep. VL - 6 UR - https://doi.org/10.1038/srep18949 DO - 10.1038/srep18949 ID - Sueda2016 ER - TY - JOUR AU - Wu, C. A. AU - Chao, Y. AU - Shiah, S. G. AU - Lin, W. W. PY - 2013 DA - 2013// TI - Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase JO - Biochim Biophys Acta VL - 1833 UR - https://doi.org/10.1016/j.bbamcr.2013.01.025 DO - 10.1016/j.bbamcr.2013.01.025 ID - Wu2013 ER - TY - JOUR AU - Corazao-Rozas, P. AU - Guerreschi, P. AU - Jendoubi, M. AU - Andre, F. AU - Jonneaux, A. AU - Scalbert, C. PY - 2013 DA - 2013// TI - Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor JO - Oncotarget VL - 4 UR - https://doi.org/10.18632/oncotarget.1420 DO - 10.18632/oncotarget.1420 ID - Corazao-Rozas2013 ER - TY - JOUR AU - Battello, N. AU - Zimmer, A. D. AU - Goebel, C. AU - Dong, X. AU - Behrmann, I. AU - Haan, C. PY - 2016 DA - 2016// TI - The role of HIF-1 in oncostatin M-dependent metabolic reprogramming of hepatic cells JO - Cancer Metab. VL - 4 UR - https://doi.org/10.1186/s40170-016-0141-0 DO - 10.1186/s40170-016-0141-0 ID - Battello2016 ER - TY - STD TI - Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007;11(1):37–51. ID - ref37 ER - TY - JOUR AU - Schieber, M. AU - Chandel, N. S. PY - 2014 DA - 2014// TI - ROS function in redox signaling and oxidative stress JO - Curr Biol VL - 24 UR - https://doi.org/10.1016/j.cub.2014.03.034 DO - 10.1016/j.cub.2014.03.034 ID - Schieber2014 ER - TY - JOUR AU - Sanchez, W. Y. AU - McGee, S. L. AU - Connor, T. AU - Mottram, B. AU - Wilkinson, A. AU - Whitehead, J. P. PY - 2013 DA - 2013// TI - Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.120 DO - 10.1038/bjc.2013.120 ID - Sanchez2013 ER - TY - STD TI - Ratnikov BI, Scott DA, Osterman AL, Smith JW, Ronai ZA. Metabolic rewiring in melanoma. Oncogene. 2017; 36(2):147-57. ID - ref40 ER - TY - JOUR AU - Scott, D. A. AU - Richardson, A. D. AU - Filipp, F. V. AU - Knutzen, C. A. AU - Chiang, G. G. AU - Ronai, Z. A. PY - 2011 DA - 2011// TI - Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect JO - J Biol Chem VL - 286 UR - https://doi.org/10.1074/jbc.M111.282046 DO - 10.1074/jbc.M111.282046 ID - Scott2011 ER - TY - JOUR AU - Koch, A. AU - Lang, S. A. AU - Wild, P. J. AU - Gantner, S. AU - Mahli, A. AU - Spanier, G. PY - 2015 DA - 2015// TI - Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells JO - Oncotarget VL - 6 ID - Koch2015 ER - TY - STD TI - Ho J, de Moura MB, Lin Y, Vincent G, Thorne S, Duncan LM, et al. Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol Cancer. 2012;11:76. ID - ref43 ER - TY - JOUR AU - Roche, T. E. AU - Hiromasa, Y. PY - 2007 DA - 2007// TI - Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer JO - Cell Mol Life Sci VL - 64 UR - https://doi.org/10.1007/s00018-007-6380-z DO - 10.1007/s00018-007-6380-z ID - Roche2007 ER - TY - JOUR AU - Corcoran, A. AU - Cotter, T. G. PY - 2013 DA - 2013// TI - Redox regulation of protein kinases JO - FEBS J VL - 280 UR - https://doi.org/10.1111/febs.12224 DO - 10.1111/febs.12224 ID - Corcoran2013 ER - TY - JOUR AU - Sena, L. A. AU - Chandel, N. S. PY - 2012 DA - 2012// TI - Physiological roles of mitochondrial reactive oxygen species JO - Mol Cell VL - 48 UR - https://doi.org/10.1016/j.molcel.2012.09.025 DO - 10.1016/j.molcel.2012.09.025 ID - Sena2012 ER - TY - JOUR AU - Murphy, M. P. PY - 2009 DA - 2009// TI - How mitochondria produce reactive oxygen species JO - Biochem J VL - 417 UR - https://doi.org/10.1042/BJ20081386 DO - 10.1042/BJ20081386 ID - Murphy2009 ER - TY - STD TI - Espinosa-Diez C, Miguel V, Mennerich D, Kietzmann T, Sanchez-Perez P, Cadenas S, et al. Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol. 2015;6:183–97. ID - ref48 ER - TY - JOUR AU - Haq, R. AU - Shoag, J. AU - Andreu-Perez, P. AU - Yokoyama, S. AU - Edelman, H. AU - Rowe, G. C. PY - 2013 DA - 2013// TI - Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF JO - Cancer Cell VL - 23 UR - https://doi.org/10.1016/j.ccr.2013.02.003 DO - 10.1016/j.ccr.2013.02.003 ID - Haq2013 ER - TY - JOUR AU - Anastasiou, D. AU - Poulogiannis, G. AU - Asara, J. M. AU - Boxer, M. B. AU - Jiang, J. K. AU - Shen, M. PY - 2011 DA - 2011// TI - Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses JO - Science VL - 334 UR - https://doi.org/10.1126/science.1211485 DO - 10.1126/science.1211485 ID - Anastasiou2011 ER - TY - JOUR AU - Sid, B. AU - Verrax, J. AU - Calderon, P. B. PY - 2013 DA - 2013// TI - Role of AMPK activation in oxidative cell damage: implications for alcohol-induced liver disease JO - Biochem Pharmacol VL - 86 UR - https://doi.org/10.1016/j.bcp.2013.05.007 DO - 10.1016/j.bcp.2013.05.007 ID - Sid2013 ER - TY - STD TI - Mungai PT, Waypa GB, Jairaman A, Prakriya M, Dokic D, Ball MK, et al. Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Mol Cell Biol. 2011;31(17):3531–45. ID - ref52 ER - TY - STD TI - Kaplon J, Zheng L, Meissl K, Chaneton B, Selivanov VA, Mackay G, et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature. 2013;498(7452):109–12. ID - ref53 ER - TY - JOUR AU - Signorelli, J. AU - Shah Gandhi, A. PY - 2017 DA - 2017// TI - Cobimetinib JO - Ann Pharmacother VL - 51 UR - https://doi.org/10.1177/1060028016672037 DO - 10.1177/1060028016672037 ID - Signorelli2017 ER - TY - STD TI - Moriceau G, Hugo W, Hong A, Shi H, Kong X, Yu CC, et al. Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction. Cancer Cell. 2015;27(2):240–56. ID - ref55 ER - TY - JOUR AU - Sharma, P. AU - Hu-Lieskovan, S. AU - Wargo, J. A. AU - Ribas, A. PY - 2017 DA - 2017// TI - Primary, adaptive, and acquired resistance to cancer immunotherapy JO - Cell VL - 168 UR - https://doi.org/10.1016/j.cell.2017.01.017 DO - 10.1016/j.cell.2017.01.017 ID - Sharma2017 ER -